A critical breakthrough in cancer research is emerging with the use of nanobodies to re-engage dysfunctional p53. This crucial malignant protector protein is frequently inactivated in several kinds of cancer, causing https://olivebookmarks.com/story22028514/vhh-fragments-reactivate-the-p53-protein-new-promising-approach-for-cancer-management